2025-01-17 04:00:00
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA
Corporate/ 2023-07-23
New Drug Application for Cadonilimab (PD...

HONG KONG,Sept. 24,2021-- Akeso,Inc. (the Company,9926.HK) announces that the National Medical Products Administration (the NMPA) of China h...

New Therapy to Treat Advanced Small Cell Lung Cancer ZEPZELCA® (lurbinectedin) Approved in Singapore
Health/ 2023-07-22
New Therapy to Treat Advanced Small Cell...

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release